phenobarbital has been researched along with awd 131-138 in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Löscher, W; Potschka, H; Rieck, S; Rundfeldt, C; Tipold, A | 1 |
Hoffmann, K; Löscher, W; Potschka, H; Töllner, K; Twele, F | 1 |
de Vries, F; Keefe, TJ; Löscher, W; Rundfeldt, C; Tipold, A | 1 |
Bhatti, S; Bossens, K; Daminet, S; Duchateau, L; Rick, M; Van Ham, L | 1 |
Packer, RM; Suiter, EJ; Volk, HA | 1 |
Keefe, T; Kostic, D; Löscher, W; Neßler, J; Rundfeldt, C; Tipold, A | 1 |
Bhatti, SF; Broeckx, BJ; Deforce, D; Gielen, I; Royaux, E; Van Ham, L; Van Soens, I | 1 |
Bhatti, SFM; Broeckx, BJG; Martlé, V; Royaux, E; Stee, K; Van Ham, L | 1 |
Barnett, CR; De Risio, L; Stabile, F; van Dijk, J | 1 |
4 trial(s) available for phenobarbital and awd 131-138
Article | Year |
---|---|
Clinical efficacy and safety of imepitoin in comparison with phenobarbital for the control of idiopathic epilepsy in dogs.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Epilepsy; Imidazoles; Phenobarbital | 2015 |
The effect of imepitoin, a recently developed antiepileptic drug, on thyroid parameters and fat metabolism in healthy Beagle dogs.
Topics: Animals; Anticonvulsants; Dog Diseases; Dogs; Epilepsy; Female; Imidazoles; Lipid Metabolism; Longitudinal Studies; Male; Phenobarbital; Prospective Studies; Thyroid Gland | 2016 |
Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.
Topics: Animals; Anticonvulsants; Cohort Studies; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Imidazoles; Male; Phenobarbital | 2017 |
Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
Topics: Animals; Anticonvulsants; Belgium; Bromides; Dog Diseases; Dogs; Epilepsy; Imidazoles; Phenobarbital; Potassium Compounds; Prospective Studies; Retrospective Studies; Seizures | 2017 |
5 other study(ies) available for phenobarbital and awd 131-138
Article | Year |
---|---|
Anticonvulsant efficacy of the low-affinity partial benzodiazepine receptor agonist ELB 138 in a dog seizure model and in epileptic dogs with spontaneously recurrent seizures.
Topics: Animals; Anticonvulsants; Bromides; Chronic Disease; Disease Models, Animal; Dog Diseases; Dogs; Drug Therapy, Combination; Epilepsy; Flumazenil; GABA Agonists; GABA-A Receptor Agonists; Imidazoles; Pentylenetetrazole; Phenobarbital; Potassium Compounds; Primidone; Receptors, GABA-A; Seizures; Substance Withdrawal Syndrome; Treatment Outcome | 2004 |
The novel antiepileptic drug imepitoin compares favourably to other GABA-mimetic drugs in a seizure threshold model in mice and dogs.
Topics: Animals; Anticonvulsants; Carbolines; Dogs; Dose-Response Relationship, Drug; Drug Partial Agonism; Female; GABA-A Receptor Agonists; Imidazoles; Male; Mice; Pentylenetetrazole; Phenobarbital; Seizures | 2013 |
Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy.
Topics: Animals; Anticonvulsants; Ataxia; Case-Control Studies; Dog Diseases; Dogs; Epilepsy; Gait; Imidazoles; Phenobarbital; Treatment Outcome | 2016 |
Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
Topics: Animals; Anticonvulsants; Bromides; Dog Diseases; Dogs; Drug Therapy, Combination; Epilepsy; Female; Imidazoles; Male; Phenobarbital; Potassium Compounds; Seizures; Treatment Outcome | 2017 |
Epileptic seizure frequency and semiology in dogs with idiopathic epilepsy after initiation of imepitoin or phenobarbital monotherapy.
Topics: Animals; Anticonvulsants; Cohort Studies; Dog Diseases; Dogs; Epilepsy; Imidazoles; Phenobarbital; Prospective Studies; Seizures; Treatment Outcome | 2019 |